Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Risperidone Market Growth 2022-2028

  • LP 4794402
  • 111 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Risperidone will have significant change from previous year. According to our (LP Information) latest study, the global Risperidone market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Risperidone market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Risperidone market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Risperidone market, reaching US$ million by the year 2028. As for the Europe Risperidone landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Risperidone players cover Janssen Pharmaceutica, Teva, Sun Pharmaceutical, and Aurobindo, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Risperidone market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Oral

Injectable

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Schizophrenia

Bipolar Disorder

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Janssen Pharmaceutica

Teva

Sun Pharmaceutical

Aurobindo

Cipla

Invent Farma Group

Medichem

Interquim

IPCA

RPG

Sharon

Torrent Pharmaceuticals

Temad

Wuxi Jida

Changzhou Siyao Pharmaceuticals

Ningbo Team Pharm

Zhejiang Huahai Pharmaceutical

TIPR

Qilu Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Risperidone Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Risperidone by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Risperidone by Country/Region, 2017, 2022 & 2028

2.2 Risperidone Segment by Type

2.2.1 Oral

2.2.2 Injectable

2.3 Risperidone Sales by Type

2.3.1 Global Risperidone Sales Market Share by Type (2017-2022)

2.3.2 Global Risperidone Revenue and Market Share by Type (2017-2022)

2.3.3 Global Risperidone Sale Price by Type (2017-2022)

2.4 Risperidone Segment by Application

2.4.1 Schizophrenia

2.4.2 Bipolar Disorder

2.5 Risperidone Sales by Application

2.5.1 Global Risperidone Sale Market Share by Application (2017-2022)

2.5.2 Global Risperidone Revenue and Market Share by Application (2017-2022)

2.5.3 Global Risperidone Sale Price by Application (2017-2022)

3 Global Risperidone by Company

3.1 Global Risperidone Breakdown Data by Company

3.1.1 Global Risperidone Annual Sales by Company (2020-2022)

3.1.2 Global Risperidone Sales Market Share by Company (2020-2022)

3.2 Global Risperidone Annual Revenue by Company (2020-2022)

3.2.1 Global Risperidone Revenue by Company (2020-2022)

3.2.2 Global Risperidone Revenue Market Share by Company (2020-2022)

3.3 Global Risperidone Sale Price by Company

3.4 Key Manufacturers Risperidone Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Risperidone Product Location Distribution

3.4.2 Players Risperidone Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Risperidone by Geographic Region

4.1 World Historic Risperidone Market Size by Geographic Region (2017-2022)

4.1.1 Global Risperidone Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Risperidone Annual Revenue by Geographic Region

4.2 World Historic Risperidone Market Size by Country/Region (2017-2022)

4.2.1 Global Risperidone Annual Sales by Country/Region (2017-2022)

4.2.2 Global Risperidone Annual Revenue by Country/Region

4.3 Americas Risperidone Sales Growth

4.4 APAC Risperidone Sales Growth

4.5 Europe Risperidone Sales Growth

4.6 Middle East & Africa Risperidone Sales Growth

5 Americas

5.1 Americas Risperidone Sales by Country

5.1.1 Americas Risperidone Sales by Country (2017-2022)

5.1.2 Americas Risperidone Revenue by Country (2017-2022)

5.2 Americas Risperidone Sales by Type

5.3 Americas Risperidone Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Risperidone Sales by Region

6.1.1 APAC Risperidone Sales by Region (2017-2022)

6.1.2 APAC Risperidone Revenue by Region (2017-2022)

6.2 APAC Risperidone Sales by Type

6.3 APAC Risperidone Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Risperidone by Country

7.1.1 Europe Risperidone Sales by Country (2017-2022)

7.1.2 Europe Risperidone Revenue by Country (2017-2022)

7.2 Europe Risperidone Sales by Type

7.3 Europe Risperidone Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Risperidone by Country

8.1.1 Middle East & Africa Risperidone Sales by Country (2017-2022)

8.1.2 Middle East & Africa Risperidone Revenue by Country (2017-2022)

8.2 Middle East & Africa Risperidone Sales by Type

8.3 Middle East & Africa Risperidone Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Risperidone

10.3 Manufacturing Process Analysis of Risperidone

10.4 Industry Chain Structure of Risperidone

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Risperidone Distributors

11.3 Risperidone Customer

12 World Forecast Review for Risperidone by Geographic Region

12.1 Global Risperidone Market Size Forecast by Region

12.1.1 Global Risperidone Forecast by Region (2023-2028)

12.1.2 Global Risperidone Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Risperidone Forecast by Type

12.7 Global Risperidone Forecast by Application

13 Key Players Analysis

13.1 Janssen Pharmaceutica

13.1.1 Janssen Pharmaceutica Company Information

13.1.2 Janssen Pharmaceutica Risperidone Product Offered

13.1.3 Janssen Pharmaceutica Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Janssen Pharmaceutica Main Business Overview

13.1.5 Janssen Pharmaceutica Latest Developments

13.2 Teva

13.2.1 Teva Company Information

13.2.2 Teva Risperidone Product Offered

13.2.3 Teva Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Teva Main Business Overview

13.2.5 Teva Latest Developments

13.3 Sun Pharmaceutical

13.3.1 Sun Pharmaceutical Company Information

13.3.2 Sun Pharmaceutical Risperidone Product Offered

13.3.3 Sun Pharmaceutical Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sun Pharmaceutical Main Business Overview

13.3.5 Sun Pharmaceutical Latest Developments

13.4 Aurobindo

13.4.1 Aurobindo Company Information

13.4.2 Aurobindo Risperidone Product Offered

13.4.3 Aurobindo Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Aurobindo Main Business Overview

13.4.5 Aurobindo Latest Developments

13.5 Cipla

13.5.1 Cipla Company Information

13.5.2 Cipla Risperidone Product Offered

13.5.3 Cipla Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Cipla Main Business Overview

13.5.5 Cipla Latest Developments

13.6 Invent Farma Group

13.6.1 Invent Farma Group Company Information

13.6.2 Invent Farma Group Risperidone Product Offered

13.6.3 Invent Farma Group Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Invent Farma Group Main Business Overview

13.6.5 Invent Farma Group Latest Developments

13.7 Medichem

13.7.1 Medichem Company Information

13.7.2 Medichem Risperidone Product Offered

13.7.3 Medichem Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Medichem Main Business Overview

13.7.5 Medichem Latest Developments

13.8 Interquim

13.8.1 Interquim Company Information

13.8.2 Interquim Risperidone Product Offered

13.8.3 Interquim Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Interquim Main Business Overview

13.8.5 Interquim Latest Developments

13.9 IPCA

13.9.1 IPCA Company Information

13.9.2 IPCA Risperidone Product Offered

13.9.3 IPCA Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 IPCA Main Business Overview

13.9.5 IPCA Latest Developments

13.10 RPG

13.10.1 RPG Company Information

13.10.2 RPG Risperidone Product Offered

13.10.3 RPG Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 RPG Main Business Overview

13.10.5 RPG Latest Developments

13.11 Sharon

13.11.1 Sharon Company Information

13.11.2 Sharon Risperidone Product Offered

13.11.3 Sharon Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Sharon Main Business Overview

13.11.5 Sharon Latest Developments

13.12 Torrent Pharmaceuticals

13.12.1 Torrent Pharmaceuticals Company Information

13.12.2 Torrent Pharmaceuticals Risperidone Product Offered

13.12.3 Torrent Pharmaceuticals Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Torrent Pharmaceuticals Main Business Overview

13.12.5 Torrent Pharmaceuticals Latest Developments

13.13 Temad

13.13.1 Temad Company Information

13.13.2 Temad Risperidone Product Offered

13.13.3 Temad Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Temad Main Business Overview

13.13.5 Temad Latest Developments

13.14 Wuxi Jida

13.14.1 Wuxi Jida Company Information

13.14.2 Wuxi Jida Risperidone Product Offered

13.14.3 Wuxi Jida Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Wuxi Jida Main Business Overview

13.14.5 Wuxi Jida Latest Developments

13.15 Changzhou Siyao Pharmaceuticals

13.15.1 Changzhou Siyao Pharmaceuticals Company Information

13.15.2 Changzhou Siyao Pharmaceuticals Risperidone Product Offered

13.15.3 Changzhou Siyao Pharmaceuticals Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Changzhou Siyao Pharmaceuticals Main Business Overview

13.15.5 Changzhou Siyao Pharmaceuticals Latest Developments

13.16 Ningbo Team Pharm

13.16.1 Ningbo Team Pharm Company Information

13.16.2 Ningbo Team Pharm Risperidone Product Offered

13.16.3 Ningbo Team Pharm Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Ningbo Team Pharm Main Business Overview

13.16.5 Ningbo Team Pharm Latest Developments

13.17 Zhejiang Huahai Pharmaceutical

13.17.1 Zhejiang Huahai Pharmaceutical Company Information

13.17.2 Zhejiang Huahai Pharmaceutical Risperidone Product Offered

13.17.3 Zhejiang Huahai Pharmaceutical Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Zhejiang Huahai Pharmaceutical Main Business Overview

13.17.5 Zhejiang Huahai Pharmaceutical Latest Developments

13.18 TIPR

13.18.1 TIPR Company Information

13.18.2 TIPR Risperidone Product Offered

13.18.3 TIPR Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 TIPR Main Business Overview

13.18.5 TIPR Latest Developments

13.19 Qilu Pharmaceutical

13.19.1 Qilu Pharmaceutical Company Information

13.19.2 Qilu Pharmaceutical Risperidone Product Offered

13.19.3 Qilu Pharmaceutical Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Qilu Pharmaceutical Main Business Overview

13.19.5 Qilu Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Risperidone Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Risperidone Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oral

Table 4. Major Players of Injectable

Table 5. Global Risperidone Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Risperidone Sales Market Share by Type (2017-2022)

Table 7. Global Risperidone Revenue by Type (2017-2022) & ($ million)

Table 8. Global Risperidone Revenue Market Share by Type (2017-2022)

Table 9. Global Risperidone Sale Price by Type (2017-2022) & (USD/Pcs)

Table 10. Global Risperidone Sales by Application (2017-2022) & (K Pcs)

Table 11. Global Risperidone Sales Market Share by Application (2017-2022)

Table 12. Global Risperidone Revenue by Application (2017-2022)

Table 13. Global Risperidone Revenue Market Share by Application (2017-2022)

Table 14. Global Risperidone Sale Price by Application (2017-2022) & (USD/Pcs)

Table 15. Global Risperidone Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Risperidone Sales Market Share by Company (2020-2022)

Table 17. Global Risperidone Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Risperidone Revenue Market Share by Company (2020-2022)

Table 19. Global Risperidone Sale Price by Company (2020-2022) & (USD/Pcs)

Table 20. Key Manufacturers Risperidone Producing Area Distribution and Sales Area

Table 21. Players Risperidone Products Offered

Table 22. Risperidone Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Risperidone Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Risperidone Sales Market Share Geographic Region (2017-2022)

Table 27. Global Risperidone Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Risperidone Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Risperidone Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Risperidone Sales Market Share by Country/Region (2017-2022)

Table 31. Global Risperidone Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Risperidone Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Risperidone Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Risperidone Sales Market Share by Country (2017-2022)

Table 35. Americas Risperidone Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Risperidone Revenue Market Share by Country (2017-2022)

Table 37. Americas Risperidone Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Risperidone Sales Market Share by Type (2017-2022)

Table 39. Americas Risperidone Sales by Application (2017-2022) & (K Pcs)

Table 40. Americas Risperidone Sales Market Share by Application (2017-2022)

Table 41. APAC Risperidone Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Risperidone Sales Market Share by Region (2017-2022)

Table 43. APAC Risperidone Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Risperidone Revenue Market Share by Region (2017-2022)

Table 45. APAC Risperidone Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Risperidone Sales Market Share by Type (2017-2022)

Table 47. APAC Risperidone Sales by Application (2017-2022) & (K Pcs)

Table 48. APAC Risperidone Sales Market Share by Application (2017-2022)

Table 49. Europe Risperidone Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Risperidone Sales Market Share by Country (2017-2022)

Table 51. Europe Risperidone Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Risperidone Revenue Market Share by Country (2017-2022)

Table 53. Europe Risperidone Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Risperidone Sales Market Share by Type (2017-2022)

Table 55. Europe Risperidone Sales by Application (2017-2022) & (K Pcs)

Table 56. Europe Risperidone Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Risperidone Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Risperidone Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Risperidone Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Risperidone Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Risperidone Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Risperidone Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Risperidone Sales by Application (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Risperidone Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Risperidone

Table 66. Key Market Challenges & Risks of Risperidone

Table 67. Key Industry Trends of Risperidone

Table 68. Risperidone Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Risperidone Distributors List

Table 71. Risperidone Customer List

Table 72. Global Risperidone Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Risperidone Sales Market Forecast by Region

Table 74. Global Risperidone Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Risperidone Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Risperidone Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Risperidone Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Risperidone Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Risperidone Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Risperidone Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Risperidone Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Risperidone Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Risperidone Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Risperidone Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Risperidone Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Risperidone Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Risperidone Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Risperidone Sales Forecast by Application (2023-2028) & (K Pcs)

Table 89. Global Risperidone Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Risperidone Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Risperidone Revenue Market Share Forecast by Application (2023-2028)

Table 92. Janssen Pharmaceutica Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 93. Janssen Pharmaceutica Risperidone Product Offered

Table 94. Janssen Pharmaceutica Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 95. Janssen Pharmaceutica Main Business

Table 96. Janssen Pharmaceutica Latest Developments

Table 97. Teva Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 98. Teva Risperidone Product Offered

Table 99. Teva Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. Teva Main Business

Table 101. Teva Latest Developments

Table 102. Sun Pharmaceutical Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 103. Sun Pharmaceutical Risperidone Product Offered

Table 104. Sun Pharmaceutical Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 105. Sun Pharmaceutical Main Business

Table 106. Sun Pharmaceutical Latest Developments

Table 107. Aurobindo Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 108. Aurobindo Risperidone Product Offered

Table 109. Aurobindo Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 110. Aurobindo Main Business

Table 111. Aurobindo Latest Developments

Table 112. Cipla Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 113. Cipla Risperidone Product Offered

Table 114. Cipla Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 115. Cipla Main Business

Table 116. Cipla Latest Developments

Table 117. Invent Farma Group Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 118. Invent Farma Group Risperidone Product Offered

Table 119. Invent Farma Group Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 120. Invent Farma Group Main Business

Table 121. Invent Farma Group Latest Developments

Table 122. Medichem Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 123. Medichem Risperidone Product Offered

Table 124. Medichem Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 125. Medichem Main Business

Table 126. Medichem Latest Developments

Table 127. Interquim Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 128. Interquim Risperidone Product Offered

Table 129. Interquim Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 130. Interquim Main Business

Table 131. Interquim Latest Developments

Table 132. IPCA Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 133. IPCA Risperidone Product Offered

Table 134. IPCA Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 135. IPCA Main Business

Table 136. IPCA Latest Developments

Table 137. RPG Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 138. RPG Risperidone Product Offered

Table 139. RPG Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 140. RPG Main Business

Table 141. RPG Latest Developments

Table 142. Sharon Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 143. Sharon Risperidone Product Offered

Table 144. Sharon Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 145. Sharon Main Business

Table 146. Sharon Latest Developments

Table 147. Torrent Pharmaceuticals Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 148. Torrent Pharmaceuticals Risperidone Product Offered

Table 149. Torrent Pharmaceuticals Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 150. Torrent Pharmaceuticals Main Business

Table 151. Torrent Pharmaceuticals Latest Developments

Table 152. Temad Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 153. Temad Risperidone Product Offered

Table 154. Temad Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 155. Temad Main Business

Table 156. Temad Latest Developments

Table 157. Wuxi Jida Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 158. Wuxi Jida Risperidone Product Offered

Table 159. Wuxi Jida Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 160. Wuxi Jida Main Business

Table 161. Wuxi Jida Latest Developments

Table 162. Changzhou Siyao Pharmaceuticals Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 163. Changzhou Siyao Pharmaceuticals Risperidone Product Offered

Table 164. Changzhou Siyao Pharmaceuticals Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 165. Changzhou Siyao Pharmaceuticals Main Business

Table 166. Changzhou Siyao Pharmaceuticals Latest Developments

Table 167. Ningbo Team Pharm Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 168. Ningbo Team Pharm Risperidone Product Offered

Table 169. Ningbo Team Pharm Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 170. Ningbo Team Pharm Main Business

Table 171. Ningbo Team Pharm Latest Developments

Table 172. Zhejiang Huahai Pharmaceutical Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 173. Zhejiang Huahai Pharmaceutical Risperidone Product Offered

Table 174. Zhejiang Huahai Pharmaceutical Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 175. Zhejiang Huahai Pharmaceutical Main Business

Table 176. Zhejiang Huahai Pharmaceutical Latest Developments

Table 177. TIPR Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 178. TIPR Risperidone Product Offered

Table 179. TIPR Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 180. TIPR Main Business

Table 181. TIPR Latest Developments

Table 182. Qilu Pharmaceutical Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors

Table 183. Qilu Pharmaceutical Risperidone Product Offered

Table 184. Qilu Pharmaceutical Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 185. Qilu Pharmaceutical Main Business

Table 186. Qilu Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Risperidone

Figure 2. Risperidone Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Risperidone Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Risperidone Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Risperidone Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oral

Figure 10. Product Picture of Injectable

Figure 11. Global Risperidone Sales Market Share by Type in 2021

Figure 12. Global Risperidone Revenue Market Share by Type (2017-2022)

Figure 13. Risperidone Consumed in Schizophrenia

Figure 14. Global Risperidone Market: Schizophrenia (2017-2022) & (K Pcs)

Figure 15. Risperidone Consumed in Bipolar Disorder

Figure 16. Global Risperidone Market: Bipolar Disorder (2017-2022) & (K Pcs)

Figure 17. Global Risperidone Sales Market Share by Application (2017-2022)

Figure 18. Global Risperidone Revenue Market Share by Application in 2021

Figure 19. Risperidone Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Risperidone Revenue Market Share by Company in 2021

Figure 21. Global Risperidone Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Risperidone Revenue Market Share by Geographic Region in 2021

Figure 23. Global Risperidone Sales Market Share by Region (2017-2022)

Figure 24. Global Risperidone Revenue Market Share by Country/Region in 2021

Figure 25. Americas Risperidone Sales 2017-2022 (K Pcs)

Figure 26. Americas Risperidone Revenue 2017-2022 ($ Millions)

Figure 27. APAC Risperidone Sales 2017-2022 (K Pcs)

Figure 28. APAC Risperidone Revenue 2017-2022 ($ Millions)

Figure 29. Europe Risperidone Sales 2017-2022 (K Pcs)

Figure 30. Europe Risperidone Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Risperidone Sales 2017-2022 (K Pcs)

Figure 32. Middle East & Africa Risperidone Revenue 2017-2022 ($ Millions)

Figure 33. Americas Risperidone Sales Market Share by Country in 2021

Figure 34. Americas Risperidone Revenue Market Share by Country in 2021

Figure 35. United States Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Risperidone Sales Market Share by Region in 2021

Figure 40. APAC Risperidone Revenue Market Share by Regions in 2021

Figure 41. China Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Risperidone Sales Market Share by Country in 2021

Figure 48. Europe Risperidone Revenue Market Share by Country in 2021

Figure 49. Germany Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Risperidone Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Risperidone Revenue Market Share by Country in 2021

Figure 56. Egypt Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Risperidone Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Risperidone in 2021

Figure 62. Manufacturing Process Analysis of Risperidone

Figure 63. Industry Chain Structure of Risperidone

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390